Stockscreener 앱 받기
8.74
3.19%
0.27
시간 외 거래:
8.79
0.05
+0.57%
전일 마감가:
$8.47
열려 있는:
$8.5
하루 거래량:
2.62M
Relative Volume:
2.58
시가총액:
$622.20M
수익:
-
순이익/손실:
$-34.98M
주가수익비율:
-9.501
EPS:
-0.9199
순현금흐름:
$-32.77M
1주 성능:
+9.11%
1개월 성능:
-12.07%
6개월 성능:
+47.14%
1년 성능:
+264.17%
1일 변동 폭
$8.19
$8.89
1주일 범위
$8.02
$8.89
52주 변동 폭
$1.94
$11.61
Immix Biopharma Inc Stock (IMMX) Company Profile
명칭
Immix Biopharma Inc
전화
(888) 958-1084
주소
11400 WEST OLYMPIC BLVD., LOS ANGELES
Compare IMMX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
8.74 | 602.98M | 0 | -34.98M | -32.77M | -0.9199 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immix Biopharma Inc Stock (IMMX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-25 | 개시 | Morgan Stanley | Overweight |
| 2026-03-09 | 개시 | Citizens | Mkt Outperform |
| 2026-02-09 | 개시 | Mizuho | Outperform |
Immix Biopharma Inc 주식(IMMX)의 최신 뉴스
IMMX Q1 2026 Earnings: Biotech Reports Narrower-than-Expected Loss, Shares GainEPS Estimate Trend - newsline.com
Immix Biopharma Surges 5.3% as Biotech Sentiment Lifts IMMXProfit Surge Picks - newsline.com
Wall Street analysts see a 120.59% upside in Immix Biopharma (IMMX): Can the stock really move this high? - MSN
What's going on with Immix Biopharma stock Thursday? - MSN
Janus Henderson files 13G/A: 9.09M shares of Immix Biopharma (IMMX) - Stock Titan
IMMX News | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
These 10 small-cap U.S. healthcare companies carry the market's most expensive valuations - Seeking Alpha
IMMX Technical Analysis | Trend, Signals & Chart Patterns | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
Immix Biopharma, Inc. Files Form 8-K Announcing Election of Directors and Corporate Details (May 2026) - Minichart
Immix Biopharma Shareholders Back Board and Auditor at AGM - TipRanks
Immix Biopharma (NASDAQ: IMMX) posts 2026 annual shareholder voting outcomes - Stock Titan
Immix Biopharma (IMMX) awards RSUs and stock options to director Helen Adams - Stock Titan
Immix Biopharma (IMMX) director Carey Ng awarded RSUs, 12,500-share option - Stock Titan
Immix Biopharma (NASDAQ: IMMX) grants RSUs and stock options to director - Stock Titan
Immix Biopharma (IMMX) CFO, President awarded 500,000 stock options at $8.78 - Stock Titan
Immix Biopharma (IMMX) director receives 6,250 RSUs and 12,500 options - Stock Titan
Immix Biopharma (IMMX) awards CEO 500,000 stock options at $8.78 strike - Stock Titan
Immix Biopharma (IMMX) director awarded RSUs and stock options in new grants - Stock Titan
Immix Biopharma (IMMX) board member receives new RSU and stock option awards - Stock Titan
Immix Biopharma (IMMX) director Jane Buchan awarded RSUs and 12,500 stock options - Stock Titan
Immix Biopharma (IMMX) Edges Higher as Biotech Sentiment ShiftsLiquidity Order Flow - newsline.com
Immix Biopharma Q1 2026 Earnings: Narrower-than-Expected Loss Drives Modest Stock UptickQuarterly Profit Report - newsline.com
Wall Street Analysts See a 120.59% Upside in Immix Biopharma (IMMX): Can the Stock Really Move This High? - Yahoo Finance
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX) - The Globe and Mail
Mizuho Securities Maintains Immix Biopharma(IMMX.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Immix Biopharma closes $140.65 million offering - The Pharma Letter
Immix Biopharma stock price target raised to $20 by H.C. Wainwright on trial data - Investing.com Nigeria
IMMX Q1 2026 Earnings: Narrowed Loss as Biotech Advances Oncology PipelineEarnings Outlook Update - Newser
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock - The Manila Times
Immix Biopharma closes $140.65 million stock offering By Investing.com - Investing.com Australia
Immix Biopharma Announces Closing of $150 Mil - Moomoo
Immix Biopharma closes $140.65 million stock offering - Investing.com UK
IMMX Maintained by HC Wainwright & Co. -- Price Target Raised to $20 - GuruFocus
Immix Biopharma, Inc. Closes $140.65 Million Underwritten Registered Offering of Common Stock - Quiver Quantitative
Biotech Immix Biopharma pulls in $140.65M from new stock sale - Stock Titan
Immix Biopharma Is Maintained at Buy by HC Wainwright & Co. - Moomoo
Immix Biopharma Price Target Raised to $20.00/Share From $15.00 by HC Wainwright & Co. - Moomoo
Immix Biopharma price target raised to $20 from $15 at H.C. Wainwright - TipRanks
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock - Sahm
Immix Biopharma Announces $150 Million Stock Offering to Fund NXC-201 AL Amyloidosis Therapy Development - Minichart
Immix Biopharma Raises $150 Million to Advance NXC-201 - TipRanks
Immix Biopharma (NASDAQ: IMMX) prices $150M common stock sale - Stock Titan
Immix Biopharma (IMMX) to raise ~$140.7M net via 16.78M-share sale - Stock Titan
What's Going On With Immix Biopharma Stock Thursday? - Benzinga
Immix Biopharma Prices $150 Million Stock Offering - Moomoo
Immix Biopharma prices $150 million stock offering at $8.94 By Investing.com - Investing.com South Africa
Immix Biopharma reports 95% complete response rate in trial By Investing.com - Investing.com South Africa
Sector Update: Healthcare - Moomoo
Immix Biopharma prices $150 million stock offering at $8.94 - Investing.com
Immix Biopharma Inc (IMMX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Immix Biopharma Inc 주식 (IMMX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Morris Gabriel S | CFO |
Dec 10 '25 |
Buy |
6.58 |
770 |
5,067 |
291,429 |
| Rachman Ilya M | CEO and Chairman |
Sep 17 '25 |
Buy |
2.02 |
2,500 |
5,050 |
1,140,937 |
| Morris Gabriel S | CFO |
Sep 16 '25 |
Buy |
1.97 |
2,600 |
5,122 |
290,659 |
| Rachman Ilya M | CEO and Chairman |
Jun 18 '25 |
Buy |
2.29 |
2,178 |
4,999 |
1,138,437 |
| Morris Gabriel S | CFO |
Jun 18 '25 |
Buy |
2.28 |
2,225 |
5,071 |
288,059 |
1.27%
1.43%
자본화:
|
볼륨(24시간):